54 Attorneys General Call on Congress to Study AI and Its Harmful Effects on Children

A bipartisan coalition of 54 state and territory attorneys general urge Congress to study how artificial intelligence (AI) can and is being used to exploit children through child sexual abuse material (CSAM). The attorneys general also asked Congress to propose legislation that would protect children from those abuses. The National Association of Attorneys General (NAAG)…

Read More →

Attorneys General Urge Congress to Appropriate Funding for Legal Services Corporation

A bipartisan coalition of 37 state and territory attorneys general urge leaders of the U.S. House and Senate Appropriations Committees to allocate robust funding for the nonprofit Legal Services Corporation (LSC) in the FY2024 budget. LSC supports equal access to justice by awarding grants to nonprofit organizations that provide civil legal services to those in…

Read More →

Attorneys General Call on Congress to Improve Federal-State Cooperation to End Human Trafficking

The National Association of Attorneys General (NAAG) sent a letter on February 27, 2023 to Congressional leadership raising concerns about the National Human Trafficking Hotline and seeking assistance to preserve the critical joint federal-state effort to end trafficking. The letter, sent on behalf of a bipartisan coalition of 36 state and territory attorneys general, highlights…

Read More →

AGs to Congress: Provide Funding for the Legal Services Corporation

The National Association of Attorneys General (NAAG) sent a letter to Congress to support beneficent funding for the Legal Services Corporation (LSC). The LSC provides critical legal assistance to low-income Americans, helping families in need across the country. Nonprofit legal aid programs funded by the federal program provide services to millions of Americans annually, reaching…

Read More →

Attorneys General Support The Public Safety Officer Act of 2022

NAAG is urging Congress to pass The Public Safety Officer Support Act of 2022. The legislation addresses gaps in support for public safety officers who suffer from post-traumatic stress disorder (PTSD) associated with the high-risk nature of their jobs. In the letter signed by 53 attorneys general, the attorneys general praise the work of public…

Read More →

NAAG Challenges Efforts to Weaken Laws Against Human Trafficking & Sexual Abuse

The National Association of Attorneys General (NAAG) wrote a letter to the American Law Institute (ALI) urging them to reject proposed changes to Section 213 of the Model Penal Code (MPC) that would weaken the ability of states to prosecute sexual assault, abuse, exploitation, and trafficking crimes; jeopardize the safety of victims of these crimes;…

Read More →

NAAG Submits Comment Letter on Beneficial Ownership Regulations

Our comments are consistent with the sense of Congress, which requires that regulations “to the greatest extent practicable… collect information in a form and manner that is reasonably designed to generate a database that is highly useful to… law enforcement agencies…” NDAA § 6402(8)(C).

Read More →

Maryland et al. v. Perrigo Company, No. 1:04CV01398 (D.D.C. Aug. 17, 2004)

The FTC and states alleged that the companies had entered into a “pay-for-delay” arrangement, whereby Perrigo paid Alpharma to withdraw its generic version from the market for Children’t ibuprofen.According to the complaint, in June 1998, Perrigo and Alpharma signed an agreement allocating to Perrigo the sale of OTC children’s liquid ibuprofen for seven years. In exchange for agreeing not to compete, Alpharma received an up-front payment and a royalty on Perrigo’s sales of children’s liquid ibuprofen. The FTC received $6.25 million to compensate injured consumers. The states received $1.5 million in lieu of civil penalties. the parties were enjoined from future agreements.

Read More →

Maryland v. SmithKline Beecham Corp., No. 2:06-cv-01298-JP (E.D.Pa Mar. 27, 2006)

States sued manufacturer of antitdepressant Paxil, alleging patent misuse and sham litigation designed to prevent generic entry. Parties settled for $14 million.

Read More →

Ohio, et al, v. Bristol-Myers Squibb Co., et al.(D.D.C. 2002); see also In re Buspirone Antitrust Litigation,Case No. 01 CV 11401, MDL 1410, MDL 1413 (S .D.N.Y.)

Plaintiff States sought damages and injunctive relief, alleging that the drug company, Bristol-Myers Squibb, Co. (BMS) wrongfully maintained a monopoly on Taxol, a drug for which the Plaintiff States alleged Defendant fraudulently filed a patent. BMS’s alleged wrongful action delayed entry into the market by generic competitors of the drug, resulting in higher prices for Taxol. In 2008, plaintiff states sued BMS for failing to report accurately to the states, pursuant to the settlemen, a patent arrangement involving the drug Plavix. The company pleaded guilty to lying to the FTC and the states recovered $1.1 million in fines.

Read More →